Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
Compumedics achieves record first half sales orders and strong revenue growth
January 22, 2026 - - Latest News -
Noxopharm completes HERACLES trial with positive safety outcome for SOF-SKN
January 22, 2026 - - Latest News -
Equipping life sciences leaders to manage foreign interference risks
January 22, 2026 - - Latest News -
Telix delivers on 2025 revenue targets as Gozellix fuels next phase of growth
January 22, 2026 - - Latest News -
AusBiotech announces new advisory groups to support the life sciences sector
January 22, 2026 - - AusBiotech -
Neurizon secures global trademark protection across major pharmaceutical markets
January 20, 2026 - - Latest News -
US regulator signals path forward for Mesoblast’s cell therapy
January 20, 2026 - - Latest News